Sunday, July 21, 2024 4:35:36 PM
I am writing a book, American Cars of 1958. Check often for the latest addition. https://investorshub.advfn.com/American-Cars-of-1958-37252/
Recent LGVN News
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2024 09:12:54 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2024 09:05:32 PM
- Longeveron® Announces Third Quarter 2024 Financial Results and Provides Business Update • GlobeNewswire Inc. • 11/12/2024 09:05:00 PM
- Longeveron® Appoints Devin Blass as Chief Technology Officer and SVP of Chemistry, Manufacturing and Controls (CMC) • GlobeNewswire Inc. • 11/11/2024 02:05:00 PM
- Longeveron® to Report Third Quarter 2024 Financial Results and Host Conference Call on November 12, 2024 • GlobeNewswire Inc. • 11/04/2024 09:05:00 PM
- Longeveron® Presents Lomecel-B™ Data for Alzheimer’s Disease Indication in Late Breaking Poster Presentation at the Clinical Trials on Alzheimer’s Disease Conference (CTAD24) • GlobeNewswire Inc. • 10/29/2024 02:00:00 PM
- Longeveron® Presents Lomecel-B™ Long-term Transplant-free Survival Data in Hypoplastic Left Heart Syndrome (HLHS) at the Congenital Heart Surgeons’ Society (CHSS) 51st Annual Meeting • GlobeNewswire Inc. • 10/27/2024 07:10:00 PM
- Longeveron® Lomecel-B™ Data in Alzheimer’s Disease Selected for Late Breaking Poster Presentation at the Clinical Trials on Alzheimer’s Disease Conference (CTAD24) • GlobeNewswire Inc. • 10/14/2024 01:05:00 PM
- Longeveron® Lomecel-B™ 5-Year Long-term Transplant-free Survival Data in HLHS Selected for Oral Presentation at the Congenital Heart Surgeons’ Society (CHSS) 51st Annual Meeting • GlobeNewswire Inc. • 10/09/2024 01:05:00 PM
- Longeveron® to Present at the UBS Virtual Organ Restoration and Cell Therapy Day • GlobeNewswire Inc. • 10/07/2024 01:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/03/2024 10:30:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/03/2024 10:30:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/03/2024 10:30:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/03/2024 10:30:10 PM
- Longeveron® to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference • GlobeNewswire Inc. • 10/02/2024 01:05:00 PM
- Longeveron to Attend Alliance for Regenerative Medicine’s Cell & Gene Meeting on the Mesa • GlobeNewswire Inc. • 09/26/2024 01:05:00 PM
- Longeveron® Announces Positive Type C Meeting with U.S. FDA Regarding Pathway to BLA for Lomecel-B™ in Hypoplastic Left Heart Syndrome (HLHS) • GlobeNewswire Inc. • 09/03/2024 01:00:00 PM
- Longeveron to Present at the H.C. Wainwright 26th Annual Global Investment Conference • GlobeNewswire Inc. • 08/26/2024 08:05:00 PM
- Cisco Beats Estimates and Announces Restructuring, Canoo Rises 6%, Lulus Losses Widen, Latest in Earnings • IH Market News • 08/15/2024 10:08:19 AM
- Longeveron® Announces Second Quarter 2024 Financial Results and Provides Business Update • GlobeNewswire Inc. • 08/14/2024 08:05:00 PM
- U.S. Futures Steady After Tuesday’s Strong Recovery; CPI in Focus • IH Market News • 08/14/2024 09:58:49 AM
- Longeveron® to Report Second Quarter 2024 Financial Results and Host Conference Call on August 14, 2024 • GlobeNewswire Inc. • 08/05/2024 08:05:00 PM
- Longeveron® Presents Study Results from CLEAR MIND Phase 2a Clinical Trial of Lomecel-B™ in Mild Alzheimer’s Disease at the Alzheimer’s Association International Conference® (AAIC) • GlobeNewswire Inc. • 07/28/2024 08:51:00 PM
- Longeveron Announces Closing of $9.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules • GlobeNewswire Inc. • 07/19/2024 08:05:00 PM
- Longeveron Announces $9.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules • GlobeNewswire Inc. • 07/18/2024 12:45:00 PM
VAYK Renewed JV to Renovate Historic Landmark into "Most Sought-after Airbnb Place" in Downtown Atlanta • VAYK • Dec 12, 2024 9:36 AM
Silexion Is Addressing the MOST COMMON Human Cancer Gene Mutation With RNAi; Recent M&As in the Field Were for Tens of Billions - $SLXN • SLXN • Dec 11, 2024 9:22 AM
Actelis Networks Bags Significant Orders for Seattle and Washington D.C. New Report Shows Their Potential as Smart City Market.. • ASNS • Dec 11, 2024 8:30 AM
Consumer Automotive Finance, Inc. Cancels an Additional 50 Million Common Shares with Shareholder Commitment to Retire 250 Million More Common Shares • CAFI • Dec 10, 2024 1:30 PM
Strategic Investments Spark Renewed Interest in Multi-Club Ownership Models • MSGS • Dec 10, 2024 1:11 PM
Consumer Automotive Finance, Inc. (OTC: CAFI) Files Form 15c2-11 to Enhance Transparency and Compliance • CAFI • Dec 9, 2024 9:30 AM